The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Create account Sign in

Clinical research

Intracoronary application of abciximab in patients with ST-elevation myocardial infarction

EuroInterv.2008;3:465-469.

Jochen Wöhrle
Jochen Wöhrle*, MD, FESC; Thorsten Nusser, MD; Christine Mayer, MD; Matthias Kochs, MD; Vinzenz Hombach, MD
Department of Internal Medicine II, University of Ulm, Ulm, Germany

Aims: Abciximab provides dose-dependent antiplatelet and anti-inflammatory properties. No specifically designed prospective studies have addressed the role of intracoronary bolus administra

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

myocardial infarctionthrombolysisreperfusionfollow-upglycoprotein iib/iiia inhibitor
Share on Facebook Share on Twitter Share on Linkedin

Read next article

Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent

Latest news

NEW ISSUE
LM revascularisation, annulus rupture, risk stratification, renal denervation
May 20, 2020
NEW
EAPCI survey results: The impact of COVID-19
Marco Roffi, Dariusz Dudek, et al.
June 3, 2020
Editorial
A perspective from EAPCI Women and Women as One
Gill Louise Buchanan
June 3, 2020
Trials Book
Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI
(supported by Biotronik)
May 14, 2020
Guidance Papers
Guidelines, consensus & position papers
May 14, 2019
NEW
EuroIntervention new Editorial Board
June 3, 2020
JAA
This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...
June 2, 2020